HGC Investment Management’s Bellevue Life Sciences Acquisition Corp. Unit BLACU Stock Holding History

HGC Investment Management’s Portfolio BLACU Stock Details BLACU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-300,000	Closed	-$3.2M	–	123
2023 Q3	$3.2M	Hold	300,000	–	–	1.05%	26
2023 Q2	$3.18M	Hold	300,000	–	–	1.15%	24
2023 Q1	$3.09M	Buy	+300,000	New	+$3.07M	0.63%	51

Other funds holding BLACU

Clear Street New York $24.6B AUM 56.26% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

HGC Investment Management's BLACU Position: Q4 2023 in Review

HGC Investment Management sold out of Bellevue Life Sciences Acquisition Corp. Unit (BLACU) in Q4 2023, closing a stake of 300,000 shares — an estimated $3.2M sold.

HGC Investment Management first reported a position in BLACU in Q1 2023 and held it in 3 quarters. The position peaked at $3.2M in Q3 2023. 2 funds tracked by Wall St. Rank hold BLACU as of Q4 2023.

HGC Investment Management reported no remaining Bellevue Life Sciences Acquisition Corp. Unit position as of Q4 2023 after selling out during the quarter.
HGC Investment Management sold 300,000 Bellevue Life Sciences Acquisition Corp. Unit shares in Q4 2023, an estimated $3.2M.
HGC Investment Management first reported a position in Bellevue Life Sciences Acquisition Corp. Unit in Q1 2023 and held it in 3 quarters.
HGC Investment Management's Bellevue Life Sciences Acquisition Corp. Unit position peaked at $3.2M in Q3 2023.
2 funds tracked by Wall St. Rank held Bellevue Life Sciences Acquisition Corp. Unit as of Q4 2023.

Based on HGC Investment Management's 13F filing for Q4 2023, filed 14 Feb 2024.